Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2025-07-03
Original market date: See footnote 1
1996-10-17
Product name:
ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP
DIN:
01960865 Electronic product monograph is not available
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
5
Schedule(s):
ETHICAL
Anatomical Therapeutic Chemical (ATC): See footnote 4
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Active ingredient group (AIG) number:See footnote5
0514462001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ADENINE | 17.3 MG / 63 ML |
| CITRIC ACID | 189 MG / 63 ML |
| DEXTROSE | 2 G / 63 ML |
| SODIUM CITRATE | 1.66 G / 63 ML |
| SODIUM PHOSPHATE MONOBASIC | 140 MG / 63 ML |